Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 2, pp. 614-626
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 13, 2018
- Revision received August 19, 2019
- Accepted November 14, 2019
- Published first November 19, 2019.
Article Versions
- Previous version (November 19, 2019 - 07:17).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Lluís Nisa1,2,3,
- Paola Francica1,2,
- Roland Giger3,
- Matúš Medo1,2,
- Olgun Elicin2,
- Manja Friese-Hamim4,
- Claudia Wilm4,
- Christopher Stroh4,
- Beat Bojaxhiu2,
- Aurélie Quintin1,2,
- Marco D. Caversaccio3,
- Matthias S. Dettmer5,
- Mélanie Buchwalder3,5,
- Tess M. Brodie1,2,6,
- Daniel M. Aebersold1,2,
- Yitzhak Zimmer1,2,
- Thomas E. Carey7,8, and
- Michaela Medová1,2,*
- 1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
- 2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
- 3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
- 4Translational Innovation Platform Oncology, Merck HealthCare KGaA, Darmstadt, Germany.
- 5Institute of Pathology, University of Bern, Bern, Switzerland.
- 6Mass Cytometry Facility, University of Zurich, Zurich, Switzerland.
- 7Department of Otolaryngology – Head and Neck Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan.
- 8Comprehensive Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan.
- ↵*Corresponding Author:
Michaela Medová, Inselspital, Bern University Hospital, and University of Bern, Murtenstrasse 35, 3008 Bern, Switzerland. Phone: 41-3163-23565; Fax: 41-3163-23297; E-mail: michaela.medova{at}dbmr.unibe.ch
February 2020
Volume 19, Issue 2
Volume 19, Issue 2
Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Jump to section
Advertisement